Your browser doesn't support javascript.
loading
A Patient-level Analysis of Efficacy and Hypoglycaemia Outcomes Across Treat-to-target Trials with Insulin Glargine Added to Oral Antidiabetes Agents in People with Type 2 Diabetes.
DeVries, J Hans; Meneghini, Luigi; Barnett, Anthony H; Reid, Timothy; Dain, Marie-Paule; Landgraf, Wolfgang; Vlajnic, Aleksandra; Traylor, Louise; Bergenstal, Richard M.
Affiliation
  • DeVries JH; Consultant Endocrinologist, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Meneghini L; Professor, University of Texas Southwestern Medical Center, Dallas, Texas, US.
  • Barnett AH; Honorary Consultant and Professor of Medicine, Heart of England NHS Foundation Trust and University of Birmingham, Birmingham, UK.
  • Reid T; Medical Director, Mercy Diabetes Center, Janesville, Wisconsin, US.
  • Dain MP; Sanofi, Paris, France.
  • Landgraf W; Sanofi, Frankfurt, Germany and Third Medical Clinic, University of Dresden, Dresden, Germany.
  • Vlajnic A; Sanofi US Inc., Bridgewater, New Jersey, US.
  • Traylor L; Sanofi US Inc., Bridgewater, New Jersey, US.
  • Bergenstal RM; Executive Director and Research Clinician, International Diabetes Center at Park Nicollet, Minneapolis, Minnesota, US.
Eur Endocrinol ; 10(1): 23-30, 2014 Feb.
Article in En | MEDLINE | ID: mdl-29872460
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: Eur Endocrinol Year: 2014 Type: Article Affiliation country: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: Eur Endocrinol Year: 2014 Type: Article Affiliation country: Netherlands